NCT/Study#
NA /
SALA-002-EW16
Phase 1 Trial of the LSD1 Inhibitor Seclidemstat (SP 2577) With and Without Topotecan and Cyclophosphamide in Patients With Relapsed or Refractory Ewing Sarcoma and Select Sarcomas
DISEASE GROUP:
Skin and Soft Tissue
current phase:
NA
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information:
Call 201-518-3587
